Healthcare IT professional with over 20 years industry experience with emphasis on providing ML/AI solutions for drug discovery.

I am passionate about pushing the boundaries of using artificial intelligence and machine learning in drug discovery. A key focus for me has been on building both the team within BioPharmaceuticals R&D and collaborating with external experts to advance innovation in drug design and synthesis.

Through a pioneering collaboration with the University of Muenster, my team demonstrated the first application of recurrent Neural Networks to molecular design which has been published in two recent, highly-cited articles. This methodology allows us to design novel drug molecules using machine learning to navigate the breadth of chemical space and to exploit our vast knowledge base.